Q4 2024 Earnings Call Transcript March 17, 2025 Quanterix Corporation misses on earnings expectations. Reported EPS is $-0.3 ...

High-sensitivity immunoassay firm Quanterix, for instance, applied its Simoa technology to measuring blood-based neurology markers like neurofilament light chain (NfL) as well as Alzheimer's-linked ...

Department of Applied Chemistry, Faculty of Science and Technology, Keio University, 3-14-1 Hiyoshi, Kohoku-ku, Yokohama, Kanagawa 223-8522, Japan ...

We collected matching plasma and CSF samples of a clinically diagnosed cohort of 35 cognitively normal, 34 aMCI, 17 naMCI, and 31 AD dementia cases (total 117 participants) with supplemental CSF Aβ42 ...

Here, we apply these polymeric coacervates to develop an innovative sandwich immunoassay diagnostic platform, which we term a one-pot Selective Target Enrichment by Polymer (oneSTEP) immunoassay.

Simoa is a breakthrough in biomarker detection due to its extremely high sensitivity and specificity. This technology combines single-molecule immunocapture with fluorescence detection, capable of ...

Our group studies neuroinflammation in multiple neurological conditions (e.g. Multiple Sclerosis, Autoimmune Encephalitis and Brain Cancer), with a focus on the role of innate immunity and purinergic ...